ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 30 filers reported holding ELIEM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,122 | -6.1% | 29,704 | -0.0% | 0.00% | 0.0% |
| Q2 2023 | $83,177 | +96617.4% | 29,706 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $86 | -23.2% | 29,706 | -2.9% | 0.00% | -50.0% |
| Q4 2022 | $112 | -99.9% | 30,607 | -0.0% | 0.00% | 0.0% |
| Q3 2022 | $99,000 | +7.6% | 30,619 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $92,000 | -76.2% | 30,619 | -33.6% | 0.00% | -77.8% |
| Q1 2022 | $387,000 | -81.1% | 46,092 | -76.4% | 0.01% | -73.5% |
| Q4 2021 | $2,044,000 | -60.4% | 195,458 | -32.0% | 0.03% | -59.5% |
| Q3 2021 | $5,166,000 | – | 287,294 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 1,658,170 | $4,808,693 | 4.16% |
| RA Capital Management | 13,150,849 | $38,137,462 | 0.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 485,955 | $1,409,270 | 0.58% |
| Atom Investors LP | 78,886 | $228,769 | 0.12% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 673,684 | $1,953,684 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 55,223 | $160,147 | 0.00% |
| Chicago Partners Investment Group LLC | 18,520 | $52,412 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 29,706 | $86 | 0.00% |
| NORTHERN TRUST CORP | 11,247 | $32,616 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |